Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-070691

SVP & Chief Commercial Officer acquired 37,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NORTHCOTT JOHN SVP & Chief Commercial Officer 2021-12-16 Grant or award +37,800 232,654 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
NORTHCOTT JOHN SVP & Chief Commercial Officer 2021-12-16 Grant or award · Stock Option +67,150 67,150 D: show line 2 in the form
Loading xslF345X03/doc4.xml…